Cigna Lifts 2026 EPS Guidance to at Least $30.60 After In-Line Q3
CI sits 20% above its 52-week low of $255.528.
Summary
Cigna raised full-year 2026 adjusted income from operations guidance to at least $30.60 a share, up $0.15 from the prior at-least $30.45 floor, and lifted Cigna Healthcare pre-tax adjusted income guidance by $50 million to at least $4.6 billion. The quarter itself was steady rather than spectacular: adjusted income from operations of $2.1 billion, or $7.98 a share, versus $7.83 a year earlier, with growth in Cigna Healthcare and Specialty and Care Services offset by a weaker Pharmacy Benefit Services contribution. Revenue rose 6% to $73.7 billion, and adjusted revenue climbed to $73.79 billion from $69.57 billion. Reported net income fell to $1.4 billion, or $5.47 a share, from $1.9 billion, or $6.98, but that gap is the absence of last year's after-tax gain on sale, not operating deterioration. The guidance bump is small in dollar terms but it comes after the October ACA marketplace exit and trimmed insurance growth target, so it tells traders the core Evernorth and Healthcare engines are still carrying the year. Management reiterated at least 10% adjusted EPS growth for 2027 off the run-rate for ongoing businesses.
At the time of this announcement, CI was trading at $307.26 on NYSE in the Life Sciences sector, with a market capitalization of approximately $80.7B. The 52-week trading range was $255.53 to $316.27. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.